Is the Hatch-Waxman System Broken?ByPeter C. Richardson,Traci Medford-RosowJanuary 6th 2016While the 1984 Act has been a boon for lower-cost generics, its goal of incentivizing new drug discovery has failed.
FTC v. Actavis: The Wrong End of the TelescopeByPeter C. Richardson,Traci Medford-RosowMarch 25th 2014On December 8, 2012, the Supreme Court agreed to hear the Federal Trade Commission (FTC) v. Actavis, Inc. case.